Global Cardiology Academy - Global Cardiology Academy

Global Cardiology Academy

Welcome to Global
Cardiology Academy

Enhance your cardiology practice with CME and
tools focused on heart health management.

Popular

Hypertension in Women: Cardiovascular Risk Across the Lifespan
Hypertension in Women: Cardiovascular Risk Across the Lifespan
Heart Matters
Hypertension in Women: Cardiovascular Risk Across the Lifespan
Shelina Ramnarine, PhD; Payal Kohli, MD, FACC
- Shelina Ramnarine, PhD
- Payal Kohli, MD, FACC
Multi-Omics Brings New Clarity to the REHAB-PH Trial
Multi-Omics Brings New Clarity to the REHAB-PH Trial
Clinician's Roundtable
Multi-Omics Brings New Clarity to the REHAB-PH Trial
Targeting the Hippo Pathway in Pulmonary Arterial Hypertension
Targeting the Hippo Pathway in Pulmonary Arterial Hypertension
AudioAbstracts
Targeting the Hippo Pathway in Pulmonary Arterial Hypertension
Ryan Quigley
- Ryan Quigley
PiB PET Uncovers Hidden ATTR-CM
PiB PET Uncovers Hidden ATTR-CM
Heart Matters
PiB PET Uncovers Hidden ATTR-CM
Recognizing ATTR-CA in Cardioembolic Stroke: Emerging Diagnostic Clues
Recognizing ATTR-CA in Cardioembolic Stroke: Emerging Diagnostic Clues
Heart Matters
Recognizing ATTR-CA in Cardioembolic Stroke: Emerging Diagnostic Clues
Exploring Deeper Silencing in Transthyretin Amyloidosis
Exploring Deeper Silencing in Transthyretin Amyloidosis
AudioAbstracts
Exploring Deeper Silencing in Transthyretin Amyloidosis
Ryan Quigley
- Ryan Quigley
Early Recognition of ATTR-CM: Key Signs and Diagnostic Strategies
Early Recognition of ATTR-CM: Key Signs and Diagnostic Strategies
Heart Matters
Early Recognition of ATTR-CM: Key Signs and Diagnostic Strategies
Valmiki Maharaj, MD
- Valmiki Maharaj, MD
Recognizing and Managing Swelling in ATTR-CM
Recognizing and Managing Swelling in ATTR-CM
On the Frontlines of ATTR-CM
Recognizing and Managing Swelling in ATTR-CM
Steve Jackson, PharmD; Kevin S. Shah, MD
- Steve Jackson, PharmD
- Kevin S. Shah, MD

Programs

CME/CE In-Person Event
Translating Evidence Into Practice: Myosin Inhibition Across the HCM Spectrum
August 30, 2026
Munich
0.75 credits
CME/CE In-Person Event
Moving the Needle in oHCM: The Era of Cardiac Myosin Inhibitors
August 29, 2026
Munich
0.75 credits
Recognizing ATTR-CM in High-Risk Populations
Recognizing ATTR-CM in High-Risk Populations
On the Frontlines of ATTR-CM
Recognizing ATTR-CM in High-Risk Populations
Steve Jackson, PharmD; Frederick Ruberg, MD
- Steve Jackson, PharmD
- Frederick Ruberg, MD
Early Detection of ATTR-CM: Clinical Clues and Imaging Approaches
Early Detection of ATTR-CM: Clinical Clues and Imaging Approaches
On the Frontlines of ATTR-CM
Early Detection of ATTR-CM: Clinical Clues and Imaging Approaches
Shelina Ramnarine, PhD; Valmiki Maharaj, MD
- Shelina Ramnarine, PhD
- Valmiki Maharaj, MD
Translating Evidence Into Action: Nonsteroidal MRAs in Patients With HF
Translating Evidence Into Action: Nonsteroidal MRAs in Patients With HF
CME/CE
Translating Evidence Into Action: Nonsteroidal MRAs in Patients With HF
Muthiah Vaduganathan, MD, MPH; Koichiro Kinugawa, MD
0.25 credits
- Muthiah Vaduganathan, MD, MPH
- Koichiro Kinugawa, MD
- Michael Böhm, MD
0.25 credits
Understanding the Mechanisms Behind Resistant Hypertension
Understanding the Mechanisms Behind Resistant Hypertension
Heart Matters
Understanding the Mechanisms Behind Resistant Hypertension
Steve Jackson, PharmD; Jan Basile, MD
- Steve Jackson, PharmD
- Jan Basile, MD
- Michael J. Bloch, MD, FAHA, FASH, FNLA, FSVM, FACP
Understanding Residual Cardiovascular Risk in CKD and T2D
Understanding Residual Cardiovascular Risk in CKD and T2D
Diabetes Discourse
Understanding Residual Cardiovascular Risk in CKD and T2D
John W. Ostrominski, MD, MPH
- John W. Ostrominski, MD, MPH
Finerenone Efficacy and Safety in Patients With CKD Regardless of Diabetes Status: Insights From the INFINITY Dataset
Finerenone Efficacy and Safety in Patients With CKD Regardless of Diabetes Status: Insights From the INFINITY Dataset
Nephrology
Finerenone Efficacy and Safety in Patients With CKD Regardless of Diabetes Status: Insights From the INFINITY Dataset
Rajiv Agarwal, MBBS, MD, FASN, BRCU
- Rajiv Agarwal, MBBS, MD, FASN, BRCU

Clinical Practice

CME/CE In-Person Event
Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
August 29, 2026
Munich
0.75 credits
AI in Pulmonary Hypertension Demonstrates Progress—with Caveats
AI in Pulmonary Hypertension Demonstrates Progress—with Caveats
Clinician's Roundtable
AI in Pulmonary Hypertension Demonstrates Progress—with Caveats
Closing Diagnostic Gaps in ATTR-CM
Closing Diagnostic Gaps in ATTR-CM
Heart Matters
Closing Diagnostic Gaps in ATTR-CM
Ronald Witteles, MD
- Ronald Witteles, MD
Understanding Real-World Testing Patterns in ATTR-CM
Understanding Real-World Testing Patterns in ATTR-CM
On the Frontlines of ATTR-CM
Understanding Real-World Testing Patterns in ATTR-CM
Steve Jackson, PharmD; Ronald Witteles, MD
- Steve Jackson, PharmD
- Ronald Witteles, MD
Finerenone Subgroup Analyses in Patients With Glomerulonephritis
Finerenone Subgroup Analyses in Patients With Glomerulonephritis
Nephrology
Finerenone Subgroup Analyses in Patients With Glomerulonephritis
Brendon Neuen, MBBS, PhD
- Brendon Neuen, MBBS, PhD
Swing for the Fences – LDL-C as the Power Hitter
Swing for the Fences – LDL-C as the Power Hitter
MinuteCE®
Swing for the Fences – LDL-C as the Power Hitter
J.A. Randy Englert, MD, FACC; Matthew Malachowski, Pharm. D., MHA
0.75 program credits
- J.A. Randy Englert, MD, FACC
- Matthew Malachowski, Pharm. D., MHA
0.75 program credits
Extra Innings – Sustaining Victory Beyond the First Game
Extra Innings – Sustaining Victory Beyond the First Game
MinuteCE®
Extra Innings – Sustaining Victory Beyond the First Game
J.A. Randy Englert, MD, FACC; Matthew Malachowski, Pharm. D., MHA
0.75 program credits
- J.A. Randy Englert, MD, FACC
- Matthew Malachowski, Pharm. D., MHA
0.75 program credits
MinuteCE®
ASCVD Playbook | Closing the Gaps, One Inning at a Time
J.A. Randy Englert, MD, FACC; Matthew Malachowski, Pharm. D., MHA
0.75 credits 6 episodes
- J.A. Randy Englert, MD, FACC
- Matthew Malachowski, Pharm. D., MHA
0.75 credits 6 episodes

CME

Unblocking Clinical Inertia: The CMI Era in oHCM Care
Unblocking Clinical Inertia: The CMI Era in oHCM Care
CME/CE Broadcast Replay
Unblocking Clinical Inertia: The CMI Era in oHCM Care
Iacopo Olivotto, MD; Elena Arbelo
0.75 credits
- Iacopo Olivotto, MD
- Elena Arbelo
- Silvia Aguiar
0.75 credits
Leadoff Hitter – Spotting High-Risk Players
Leadoff Hitter – Spotting High-Risk Players
MinuteCE®
Leadoff Hitter – Spotting High-Risk Players
J.A. Randy Englert, MD, FACC
0.75 program credits
- J.A. Randy Englert, MD, FACC
0.75 program credits
Small Ball Wins Games – Combination Therapy for Goal Attainment
Small Ball Wins Games – Combination Therapy for Goal Attainment
MinuteCE®
Small Ball Wins Games – Combination Therapy for Goal Attainment
J.A. Randy Englert, MD, FACC; Matthew Malachowski, Pharm. D., MHA
0.75 program credits
- J.A. Randy Englert, MD, FACC
- Matthew Malachowski, Pharm. D., MHA
0.75 program credits
Crossing Home Plate – Building a Winning Team Culture
Crossing Home Plate – Building a Winning Team Culture
MinuteCE®
Crossing Home Plate – Building a Winning Team Culture
J.A. Randy Englert, MD, FACC; Matthew Malachowski, Pharm. D., MHA
0.75 program credits
- J.A. Randy Englert, MD, FACC
- Matthew Malachowski, Pharm. D., MHA
0.75 program credits
Translating the Latest KDIGO Guidelines Into Practice: IV Iron Therapy in Patients With Non–Dialysis-Dependent CKD
Translating the Latest KDIGO Guidelines Into Practice: IV Iron Therapy in Patients With Non–Dialysis-Dependent CKD
CME/CE
Translating the Latest KDIGO Guidelines Into Practice: IV Iron Therapy in Patients With Non–Dialysis-Dependent CKD
Patrick Rossignol, MD, PhD; Julio Núñez, MD, PhD
0.25 credits
- Patrick Rossignol, MD, PhD
- Julio Núñez, MD, PhD
0.25 credits
FXIa Remix! Keeping the Flow Without Missing a Beat
FXIa Remix! Keeping the Flow Without Missing a Beat
CME/CE
FXIa Remix! Keeping the Flow Without Missing a Beat
Mike Sharma, MD, MSc, FRCPC; Ashkan Shoamanesh, MD
0.50 credits
- Mike Sharma, MD, MSc, FRCPC
- Ashkan Shoamanesh, MD
- Brian Mac Grory, MB, BCh BAO, MRCP, FAHA, FANA
0.50 credits
Hypertrophic Cardiomyopathy: Moving From Monitoring to Action in the Era of Myosin Inhibitors
Hypertrophic Cardiomyopathy: Moving From Monitoring to Action in the Era of Myosin Inhibitors
Cardiology
Hypertrophic Cardiomyopathy: Moving From Monitoring to Action in the Era of Myosin Inhibitors
Joseph Rossano, MD
- Joseph Rossano, MD
Engaging Your Patient: Shared Decision-Making in HF With LVEF ≥40%
Engaging Your Patient: Shared Decision-Making in HF With LVEF ≥40%
CME/CE
Engaging Your Patient: Shared Decision-Making in HF With LVEF ≥40%
Scott Solomon, MD
0.25 credits
- Scott Solomon, MD
0.25 credits

Medical News

Medical News
Sequential Add-On Therapy and Risk Reclassification in PAH
07/09/2026
Read more
Medical News
New Findings on Conservative Oxygen After Cardiac Arrest
07/07/2026
Read more
Medical News
Long-Term Antihypertensive Therapy and MACE Risk Across 51 Trials
07/07/2026
Read more
Medical News
Intensive LDL Cholesterol Targeting in Atherosclerotic Cardiovascular Disease
06/29/2026
Read more
Medical News
Management of Menopause for Women With Cardiovascular Disease
06/29/2026
Read more
Medical News
Meta-Analysis Links Heart Failure Therapies to Better Cardiac Function During Cancer Treatment
06/25/2026
Read more
Medical News
Triple Low-Dose Antihypertensive Pill After Intracerebral Hemorrhage
06/22/2026
Read more
Medical News
C-TRACT Trial: Endovascular Therapy Lowers PTS Severity, Improves QOL
06/22/2026
Read more